Suppr超能文献

横纹肌肉瘤:实验动物模型概述。

Rhabdomyosarcomas: an overview on the experimental animal models.

机构信息

Department of Biomedical Sciences and Biotechnologies, Interuniversity Institute of Myology (IIM), University of Brescia, Brescia, Italy.

出版信息

J Cell Mol Med. 2012 Jul;16(7):1377-91. doi: 10.1111/j.1582-4934.2011.01518.x.

Abstract

Rhabdomyosarcomas (RMS) are aggressive childhood soft-tissue malignancies deriving from mesenchymal progenitors that are committed to muscle-specific lineages. Despite the histopathological signatures associated with three main histological variants, termed embryonal, alveolar and pleomorphic, a plethora of genetic and molecular changes are recognized in RMS. Over the years, exposure to carcinogens or ionizing radiations and gene-targeting approaches in vivo have greatly contributed to disclose some of the mechanisms underlying RMS onset. In this review, we describe the principal distinct features associated with RMS variants and focus on the current available experimental animal models to point out the molecular determinants cooperating with RMS development and progression.

摘要

横纹肌肉瘤(RMS)是一种源自间充质祖细胞的侵袭性儿童软组织恶性肿瘤,这些祖细胞定向分化为肌肉特异谱系。尽管横纹肌肉瘤存在与三种主要组织学变体相关的组织病理学特征,分别称为胚胎性、肺泡性和多形性,但已确认存在大量遗传和分子改变。多年来,接触致癌剂或电离辐射以及体内的基因靶向方法极大地促进了揭示横纹肌肉瘤发病机制的一些机制。在这篇综述中,我们描述了与 RMS 变体相关的主要特征,并重点介绍了当前可用的实验动物模型,以指出与 RMS 发展和进展相关的分子决定因素。

相似文献

1
Rhabdomyosarcomas: an overview on the experimental animal models.
J Cell Mol Med. 2012 Jul;16(7):1377-91. doi: 10.1111/j.1582-4934.2011.01518.x.
3
Spindle cell rhabdomyosarcoma in adults: clinicopathological and immunohistochemical analysis of seven new cases.
Virchows Arch. 2006 Nov;449(5):554-60. doi: 10.1007/s00428-006-0284-4. Epub 2006 Sep 30.
5
[Clinicopathological study of 145 childhood rhabdomyosarcoma cases].
Zhonghua Bing Li Xue Za Zhi. 2004 Jun;33(3):225-8.
6
[Molecular mechanisms regulating metastasis of cancer cells with special emphasis on rhabdomyosarcoma].
Postepy Hig Med Dosw (Online). 2014 Mar 7;68:258-70. doi: 10.5604/17322693.1093219.
7
Pathologic classification of rhabdomyosarcomas and correlations with molecular studies.
Mod Pathol. 2001 May;14(5):506-14. doi: 10.1038/modpathol.3880339.
8
[Rhabdomyosarcoma in middle to old-aged patients: analysis of clinicopathological features and prognosis in 76 cases].
Zhonghua Zhong Liu Za Zhi. 2012 Dec;34(12):910-6. doi: 10.3760/cma.j.issn.0253-3766.2012.12.007.
10
Birth characteristics and the risk of childhood rhabdomyosarcoma based on histological subtype.
Br J Cancer. 2010 Jan 5;102(1):227-31. doi: 10.1038/sj.bjc.6605484. Epub 2009 Dec 8.

引用本文的文献

1
Contemporary preclinical mouse models for pediatric rhabdomyosarcoma: from bedside to bench to bedside.
Front Oncol. 2024 Feb 2;14:1333129. doi: 10.3389/fonc.2024.1333129. eCollection 2024.
2
Rhabdomyosarcoma: Current Therapy, Challenges, and Future Approaches to Treatment Strategies.
Cancers (Basel). 2023 Nov 2;15(21):5269. doi: 10.3390/cancers15215269.
4
Loss of p16/Ink4a drives high frequency of rhabdomyosarcoma in a rat model of Duchenne muscular dystrophy.
J Vet Med Sci. 2021 Sep 15;83(9):1416-1424. doi: 10.1292/jvms.21-0243. Epub 2021 Jul 31.
5
Preclinical In Vivo Modeling of Pediatric Sarcoma-Promises and Limitations.
J Clin Med. 2021 Apr 8;10(8):1578. doi: 10.3390/jcm10081578.
6
Cell growth potential drives ferroptosis susceptibility in rhabdomyosarcoma and myoblast cell lines.
J Cancer Res Clin Oncol. 2018 Sep;144(9):1717-1730. doi: 10.1007/s00432-018-2699-0. Epub 2018 Jul 3.
7
Immunohistochemical Characterization of Sarcomas in Trp53+/- Haploinsufficient Mice.
Toxicol Pathol. 2017 Aug;45(6):774-785. doi: 10.1177/0192623317730558.
8
A novel mouse model of rhabdomyosarcoma underscores the dichotomy of MDM2-ALT1 function in vivo.
Oncogene. 2018 Jan 4;37(1):95-106. doi: 10.1038/onc.2017.282. Epub 2017 Sep 11.
9
Iron, Oxidative Damage and Ferroptosis in Rhabdomyosarcoma.
Int J Mol Sci. 2017 Aug 7;18(8):1718. doi: 10.3390/ijms18081718.
10
transcripts in CRL-2061 rhabdomyosarcoma cells show high levels of intron retention by intron-specific PCR amplification.
Cancer Cell Int. 2017 May 23;17:58. doi: 10.1186/s12935-017-0428-4. eCollection 2017.

本文引用的文献

2
Rhabdomyosarcomas in aging A/J mice.
PLoS One. 2011;6(8):e23498. doi: 10.1371/journal.pone.0023498. Epub 2011 Aug 10.
3
Cancer in Noonan, Costello, cardiofaciocutaneous and LEOPARD syndromes.
Am J Med Genet C Semin Med Genet. 2011 May 15;157C(2):83-9. doi: 10.1002/ajmg.c.30300. Epub 2011 Apr 15.
4
Pyrrolizidine alkaloids in food: a spectrum of potential health consequences.
Food Addit Contam Part A Chem Anal Control Expo Risk Assess. 2011 Mar;28(3):308-24. doi: 10.1080/19440049.2010.547520.
7
You can win by losing: p53 mutations in rhabdomyosarcomas.
J Pathol. 2010 Oct;222(2):124-8. doi: 10.1002/path.2757.
10
Sarcomas across the age spectrum.
Semin Radiat Oncol. 2010 Jan;20(1):45-51. doi: 10.1016/j.semradonc.2009.09.003.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验